MARC details
| 000 -LEADER |
| fixed length control field |
01218cam a2200325 a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
830125s1983 dcua b 000 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
| International Standard Book Number |
0844735175 (pbk.) |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
DLC |
| Transcribing agency |
DLC |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
| Classification number |
KF3885 |
| Item number |
.G7 1983 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
344.0416 |
| Item number |
GRA |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Grabowski, Henry G. |
| 245 14 - TITLE STATEMENT |
| Title |
The regulation of pharmaceuticals : |
| Remainder of title |
balancing the benefits and risks / |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Place of publication, distribution, etc |
Washington : |
| Name of publisher, distributor, etc |
American Enterprise Institute for Public Policy Research, |
| Date of publication, distribution, etc |
c1983. |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
74 p. : |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
| Title |
AEI studies ; |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Inludes bibliographical references. |
| 520 ## - SUMMARY, ETC. |
| Summary, etc. |
The book reviews the empirical evidence concerning the FDA's effect on the rate of innovation, the delays in introducing new drugs in the United States compared with Great Britain and other countries, the profitability of pharmaceutical research, and the reduction of risk to patients resulting from regulation. |
| 590 ## - Local Notes: Cataloguer & Date |
| Local note |
oif 04/08/16 |
| 591 ## - Local Note: Item Class (Ref/Loans/Arch): Loans |
| Local Note: Item Class |
Loan |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Pharmacy |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drug industry |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Drugs |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Legislation, Drug |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Research |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
| Geographic name |
United States of America |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Vernon, John M. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Monograph & others |
| 949 ## - LOCAL PROCESSING INFORMATION (Call No. /Shelf Ref) |
| Call No. /Shelf Ref |
344.0416 GRA |